317
Participants
Start Date
October 31, 2016
Primary Completion Date
October 18, 2017
Study Completion Date
October 18, 2017
florbetapir F 18 PET scan
For those patients who do not have an existing amyloid scan, each will receive an IV injection, 370 MBq (10 mCi), single dose of florbetapir F 18 followed by a Positron Emission Tomography (PET) Scan to determine amyloid status
Richmond Behavioral Associates, Staten Island
Neurological Associates of Long Island, Lake Success
Integrative Clinical Trials, Brooklyn
Adirondack Medical Research, Glens Falls
Adler Institute for Advanced Imaging, Jenkintown
Pearl Clinical Research, Norristown
Sheppard Pratt Health System, Baltimore
Spectrum Clinical Research, Baltimore
National Clinical Research-Richmond, Inc., Richmond
iResearch Atlanta, Decatur
Doctors Clinical Research, Atlanta
Progressive Medical Research, Port Orange
Neurology Associates, PA, Maitland
Sand Lake Imaging, MRI Facility, Winter Park
Merritt Island Medical Research, Merritt Island
Direct Helpers Research, Hialeah
Healing Touch C&C Research Inc, Hialeah
Advance Research Development Solutions, Miami Lakes
Galiz Research, Hialeah
Pines Care Research Center, Pembroke Pines
Advanced Research Institute of Miami, Homestead
Homestead Associates in Research, Miami
Wisdom Clinical Research Institute, Coral Gables
Dade Research Center, Miami
Bravo Health Care Center, North Bay Village
United Clinical Research, Corp., Miami
Advanced Medical Research Institute (AMRI), Miami
New Horizon Research Center, Miami
Precision Clinical Research, Lauderdale Lakes
Laszlo J. Mate, MD, North Palm Beach
JEM Research Institute, Atlantis
Olympian Clinical Research - South Tampa Office, Tampa
Tampa Neurology Associates, Tampa
University of South Florida Health Byrd Alzheimer's Institute, Tampa
Suncoast Neuroscience Associates, Inc., St. Petersburg
Ptak Alzheimer Research Center, Clearwater
Neurostudies.net, LLC, Port Charlotte
Lovelance Scientific Resources, Inc., Venice
Hattiesburg Clinic, Hattiesburg
Clinical Inquest Center, Dublin
Dayton Center for Neurological Disorders, Dayton
Community Hospital of Anderson and Madison Country, Anderson
American Health Network of Indiana, Avon
American Health Network of Indiana, LLC, Franklin
Michigan State University, East Lansing
Dean Foundation for Health, Research and Education, Inc., Middleton
Millenium Psychiatric Associates, Creve Coeur
Cotton O'Neil Clinical Research Center, Topeka
Woodland Research Northwest, Rogers
Tulsa Clinical Research, LLC, Tulsa
The Clinical Research Group, Inc., Lewisville
FMC Science, Lampasas
Heights Doctors Clinic, Houston
Yvonne Kew MD PLLC Neuro-Oncology Clinic, Houston
Texas Medical Research Associates, LLC, San Antonio
Mile High Research Center, Denver
Center for Neuro and Spine Inc. (CNS) - Main Office, Phoenix
Imaging Endpoints, Scottsdale
Center for Neurology and Spine, Sun City
Arrowhead Internal Medicine, PC, Glendale
Las Vegas Medical Center, Las Vegas
Pacific Research Network, San Diego
Irvine Center for Clinical Research, Irvine
Senior Clinical Trials, Inc., Laguna Hills
Syrentis Clinical Research, Santa Ana
Neurology Center of North Orange County, Fullerton
North Bay Neuroscience Institute, Sebastopol
Legacy Research Institute, Portland
Coastal Conneticut Research, New London
Boston Center for Memory, Brookline
Amici Clinical Research, Martinsville
The Cognitive and Research Center of New Jersey, Springfield
Advanced Memory Research Institute of NJ, PC, Toms River
Neurology Specialists of Monmouth County, PA, West Long Branch
Rhode Island Mood and Memory Research Institute, East Providence
Lead Sponsor
Collaborators (1)
Eli Lilly and Company
INDUSTRY
PRA Health Sciences
INDUSTRY
Avid Radiopharmaceuticals
INDUSTRY